Article · 4 May 2026
Research articlePublished 26 Aug 2023
L-Citrulline versus Spironolactone in a Rat Model of Hypertension: New Insights into their Therapeutic Effects
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
L-citrulline, a natural antioxidant and nitric oxide donor, has beneficial cardiovascular properties. The present study investigated the differences in the outcomes between L-citrulline monotherapy and combination therapy with spironolactone as initial treatments for test animals with deoxycorticosterone acetate saltinduced hypertension. Deoxycorticosterone acetate salt (20 mg/kg, s.c.) was administered twice a week in male Wistar rats for 4 w with daily drinking water containing sodium chloride (1 %) and potassium chloride (0.2 %) to develop hypertension. In the development period, treatment groups received a daily dose of L-citrulline (50 or 100 mg/kg, p.o.) alone or in spironolactone (50 or 100 mg/kg, p.o.) combination. Treatment effects assessed by measuring non-invasive and invasive blood pressure, body and heart weight, vascular reactivity to catecholamines, acetylcholine-induced vasorelaxation in the isolated artery, and oxidative stress in heart specimens. Compared to the deoxycorticosterone acetate group, the L-citrulline and spironolactone combination therapy dose-dependently ameliorated the elevated levels of different blood pressure parameters, improved cardiac hypertrophy, vascular reactivity, aorta relaxant responses and attenuated oxidative stress. In addition, L-citrulline low and high-dose monotherapy demonstrated significant improvements in all evaluated parameters except vascular reactivity. However, compared to combination therapy, the performance of L-citrulline or spironolactone alone treatment is slightly inferior. Our results conclude that L-citrulline is a promising treatment option for treating hypertension, and L-citrulline can be combined with spironolactone to get a synergistic effect in treating hypertension.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “P. P. Shivgunde”
- BylineArticles whose byline prints “Vandana Nade”